CV Lattes
ORCID
Google Scholar Citations
Secretaria de Desenvolvimento Econômico (São Paulo - Estado). Faculdade de Medicina de São José do Rio Preto (FAMERP) (Institutional affiliation for the last research proposal) Birthplace: Brazil
Medical Degree, Medical School, São José do Rio Preto (1975), Master in Internal Medicine/ Nephrology at Rio de Janeiro University (1980), Reserach fellow at INSERM 25, Necker Hospital, and Medical Doctor, Paris Hospitals, (1981-1982) , Research fellow , Harvard Medical School, Peter Bent and Beth Israel Hospitals (1983 -1984), Doctorate in Health Sciences at Medical School São José do Rio Preto (2006). Associate Professor in Medicine, Medical School São José do Rio Preto, (1997 - ) Head, Depto Medicine, and Chief of nephrology Division , 1997-2020, Medical School São José do Rio Preto,Medical Director, Organ & Tissue Transplantation Center at Hospital de Base and Medical School Foundation, (1994- ), Director , Immunology and Experimental Transplantation Laboratort at Medical School São José do Rio Preto, Director Transplant Immunology Lab at Instituto de Urology & Nephrology (1986 - 2018), Emeritus Editor, Brazilian Journal Transplantation, Reviewer Transplantation, Ama J. transplantation, Transplantation Proc. Translational Med, PLOS One, 105 PubMed Indexed Publication, 22 Book Chapters, Editor, 2 Organ Transplantation books, (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| TITULO |
| Articles published in other media outlets (0 total): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Brain death (BD) triggers systemic inflammation, with consequent activation of inflammatory pathways in organs donated for transplants. Kidneys from deceased donors with extended criteria (ECD) or with high risk scores (KDPI> 85%) considered "non-ideal" kidneys, could be used, but have been discarded by Tx teams because they have inferior outcomes, worsening the shortage of organs for Tx.…
Introduction. Kidney transplantation is the treatment for patients with chronic renal failure (CRF), however, the supply of organs is insufficient. Kidneys from deceased donors with extended criteria (DCE) have been increasingly used, however, the outcomes associated with the use of ECD organs are still controversial. The most commonly observed complication after transplantation from dece…
Stem cell therapy (CT), in which there is the potential for treatment of chronic diseases, may be a promising strategy to repair and/or slow the progression of CRF. There are questions concerning cell type, the quantity of cells necessary, the best method of administration, and the ideal location for deployment of CT, and the role these cells play in the repair of renal tissue. In additio…
Introduction: Brain death (BD) triggers systemic inflammation with consequent activation of inflammatory pathways in organs donated for transplants. Kidneys from deceased donors with extended criteria (ECD) or with high risk scores (KDPI > 85%) considered "non-ideal" kidneys could be used, but have been discarded by Tx teams for having inferior outcomes, worsening the shortage of organs f…
The insufficient number of organs to attend the high numbers of patients into the waiting list is one of the most problems of kidney transplant (Tx), consequently increases the cost of the treatment, decreases the quality of life and high mortality rates. Therefore, the transplant centers have started to develop some alternatives for the organ allocation, in addition to the use of kidneys…
Introduction. Kidney transplantation is the treatment for patients with chronic renal failure (CRF), however, the supply of organs is insufficient. Kidneys from deceased donors with extended criteria (DCE) have been increasingly used, however, the outcomes associated with the use of ECD organs are still controversial. The most commonly observed complication after transplantation from dece…
Chronic renal failure (CRF) is characterized by progressive and irreversible loss of renal function and its treatment generates a public expenditure for maintenance of patients on dialysis. The stem cell therapy (CT) may be a promising strategy to repair/slow the progression of CRF. However, there are doubts about the cell type used in the repair and the role of the kidney. Preliminary da…
(Only some records are available in English at this moment)
| 1 / 1 | Ongoing research grants |
| 3 / 2 | Completed research grants |
| 1 / 1 | Ongoing scholarships in Brazil |
| 6 / 4 | Completed scholarships in Brazil |
| 11 / 8 | All research grants and scholarships |
| Associated processes | |